|
Retinopathy
References
Altomare, E., Grattagliano, I., Vendemaile, G.,
Micelli-Ferrari, T., Signorile, A., Cardia, L. Oxidative
protein damage in human diabetic eye: evidence of a retinal
participation. Eur. J. Clin. Invest. 1997 Feb; 27(2):
141-7.
Anon. Vitamins for seeing. Compr. Ther. 1990; 16(4):
62.
Bernstein, P.S., Khachik, F., Carvalho, L.S., Muir, G.J.,
Zhao, D.Y., Katz, N.B. Identification and quantitation of
carotenoids and their metabolites in the tissues of the human
eye. Exp. Eye Res. 2001 Mar; 72(3): 215-23.
Boehm, B.O., Lustig, R.H. Use of somatostatin receptor
ligands in obesity and diabetic complications. Best Pract.
Res. Clin. Gastroenterol. 2002 Jun; 16(3): 493-509.
Bursell, S.E., Clermont, A.C., Aiello, L.P., Aiello, L.M.,
Schlossman, D.K., Feener, E.P., Laffel, L., King, G.L.
High-dose vitamin E supplementation normalizes retinal blood
flow and creatinine clearance in patients with type 1
diabetes. Diabetes Care 1999 Aug; 22(8): 1245-51.
Chung, T.W., Yu, J.J., Liu, D.Z. Reducing lipid
peroxidation stress of erythrocyte membrane by
alpha-tocopherol nicotinate plays an important role in
improving blood rheological properties in type 2 diabetic
patients with retinopathy. Diabet. Med. 1998 May; 15(5):
380-5.
Di Giulio, A.M., Lesma, E., Germani, E., Gorio, A.
Inhibition of high glucose-induced protein
mono-ADP-ribosylation restores neuritogenesis and sodium-pump
activity in SY5Y neuroblastoma cells. J. Neurosci. Res. 1999
Sep 1; 57(5): 663-9.
Gorio, A., Donadoni, M.L., Finco, C., Di Giulio, A.M.
Endogenous mono-ADP-ribosylation in retina and peripheral
nervous system. Effects of diabetes. Adv. Exp. Med. Biol.
1997; 419: 289-95.
Guillausseau, P.J. Pharmacological prevention of diabetic
microangiopathy. Diabete Metabol. 1994; 20(2 BIS): 219-28.
Hotta, N., Koh, N., Sakakibara, F., Nakamura, J., Hamada,
Y., Hara, T., Fukasawa, H., Kakuta, H., Sakamoto, N. Effect of
propionyl-L-carnitine on oscillatory potentials in
electroretinogram in streptozotocin-diabetic rats. Eur. J.
Pharmacol. 1996; 311(2-3): 199-206.
KaLuzny, J. Antioxidants for prophylaxis of eye diseases.
Klin. Oczna 1996 Feb; 98(2): 141-3.
Klein, R., Klein, B.E., Moss, S.E., Cruickshanks, K.J.
Relationship of hyperglycemia to the long-term incidence and
progression of diabetic retinopathy. Arch. Intern. Med. 1994
Oct 10; 154(19): 2169-78.
Kowluru, R.A., Kern, T.S., Engerman, R.L. Abnormalities of
retinal metabolism in diabetes or experimental galactosemia.
IV. Antioxidant defense system. Free Radic. Biol. Med. 1997;
22(4): 587-92.
Leslie, R.D., Pozzilli, P. An introduction to new advances
in diabetes. Diabetes Metab. Res. Rev. 2002 Jan-Feb; 18(Suppl.
1): S1-6.
Mayer-Davis, E.J., Bell, R.A., Reboussin, B.A., Rushing,
J., Marshall, J.A., Hamman, R.F. Antioxidant nutrient intake
and diabetic retinopathy: The San Luis Valley Diabetes Study.
Ophthalmology 1998 Dec; 105(12): 2264-70.
Moeller, S.M., Jacques, P.F., Blumberg, J.B. The potential
role of dietary xanthophylls in cataract and age-related
macular degeneration. J. Am. Coll. Nutr. 2000 Oct; 19(5,
Suppl.): 522S-527S.
Niesman, M.R., Johnson, K.A., Penn, J.S. Therapeutic effect
of liposomal superoxide dismutase in an animal model of
retinopathy of prematurity. Neurochem. Res. 1997 May; 22(5):
597-605.
Papp, A., Nemeth, I., Pelle, Z., Tekulics, P. Prospective
biochemical study of the antioxidant defense capacity in
retinopathy of premokemiai vizsgalata retinopathia
preamaturorumban. Orv. Hetil. 1997 Jan 26; 138(4): 201-5.
Raccah, D., Coste, T., Cameron, N.E., Dufayet, D., Vague,
P., Hohman, T.C. Effect of the aldose reductase inhibitor
tolrestat on nerve conduction velocity, Na/K ATPase activity,
and polyols in red blood cells, sciatic nerve, kidney cortex,
and kidney medulla of diabetic rats. J. Diabetes Complications
1998 May-Jun; 12(3): 154-62.
Rapp, L.M., Maple, S.S., Choi, J.H. Lutein and zeaxanthin
concentrations in rod outer segment membranes from perifoveal
and peripheral human retina. Invest. Ophthalmol. Vis. Sci.
2000 Apr; 41(5): 1200-9.
Schalch, W. Carotenoids in the retina-a review of their
possible role in preventing or limiting damage caused by light
and oxygen. EXS 1992; 62: 280-98.
Siems, W.G., Sommerburg, O., van Kuijk, F.J. Lycopene and
beta-carotene decompose more rapidly than lutein and
zeaxanthin upon exposure to various pro-oxidants in vitro.
Biofactors 1999; 10(2-3): 105-13.
Thiagarajan, G., Chandani, S., Sundari, C.S., Rao, S.H.,
Kulkarni, A.V., Balasubramanian, D. Antioxidant properties of
green and black tea, and their potential ability to retard the
progression of eye lens cataract. Exp. Eye Res. 2001 Sep;
73(3): 393-401.
Wang, A.M., Ma, C., Xie, Z.H., Shen, F. Use of carnosine as
a natural anti-senescence drug for human beings. Biochemistry
2000 Jul; 65(7): 869-71.
Yeum, K.J., Shang, F.M., Schalch, W.M., Russell, R.M.,
Taylor, A. Fat-soluble nutrient concentrations in different
layers of human cataractous lens. Curr. Eye Res. 1999 Dec;
19(6): 502-5.
Zigman, S., Rafferty, N.S., Rafferty, K.A., Lewis, N.
Effects of green tea polyphenols on lens photooxidative
stress. Biol. Bull. 1999 Oct; 197(2): 285-6.
|